Atlas Trials

Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Clinical trial NCT02521233 · WITHDRAWN

Trial details

NCT number
NCT02521233
Sponsor
EMS
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Arterial Hypertension
Start date
2016-11-01
Primary completion
2017-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.